Hepatocellular Carcinoma: Pathology

  • Donald B. Rolfes


Hepatocellular carcinoma is the most common primary malignancy of the liver. This neoplasm is relatively rare in the United States but is the most common fatal malignancy in many parts of the world. Hepatocellular carcinoma usually develops in the cirrhotic liver of older adults. Hepatitis B infection is present in 85% of cases worldwide, although alcoholism is the most common associated disease in developed countries of the Western world.1


Hepatocellular Carcinoma Cirrhotic Liver Focal Nodular Hyperplasia Bile Canaliculus Fibrous Septum 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kew MC, Popper H: Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis 4:136–146, 1984.PubMedCrossRefGoogle Scholar
  2. 2.
    Okuda K, Musha H, Nakajima Y: Clinicopathologic features of encapsulated hepatocellular carcinoma: A study of 26 cases. Cancer 40:1240–1245, 1977.PubMedCrossRefGoogle Scholar
  3. 3.
    Anthony PP: Tumours and tumour-like lesions of the liver and biliary tract, in MacSween NM, Anthony PP, Scheuer PJ (eds): Pathology of the Liver, 2nd ed. Churchill Livingstone, Edinburgh, 1987, pp. 574–645.Google Scholar
  4. 4.
    Lai CL, Lew PC, Lam KC, et al: Histologic prognositic indicators in hepatocellular carcinoma. Cancer 44:1677–1683, 1979.PubMedCrossRefGoogle Scholar
  5. 5.
    Berman MM, Libbey NP, Foster JH: Hepatocellular carcinoma. Polygonal cell type with fibrous stroma— An atypical variant with a favorable prognosis. Cancer 46:1448–1455, 1980.PubMedCrossRefGoogle Scholar
  6. 6.
    Craig JR, Peters RL, Edmondson HA, et al: Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinicopathologic features. Cancer 46:372–379, 1980.PubMedCrossRefGoogle Scholar
  7. 7.
    Farhi DC, Shikes RH, Murari PJ, et al: Hepatocellular carcinoma in young people. Cancer 52:1516–1525, 1983.PubMedCrossRefGoogle Scholar
  8. 8.
    Goodman ZD, Ishak KG: Hepatocellular carcinoma in women: Probable lack of etiologic association with oral contraceptive steroids. Hepatology 2:440–444, 1982.PubMedCrossRefGoogle Scholar
  9. 9.
    Paradinas FJ, Melia WM, Wilkinson ML, et al: High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma. Br Med J 285:840–842, 1982.CrossRefGoogle Scholar
  10. 10.
    Collier NA, Bloom SR, Hodgson JHF, et al: Neurotensin secretion by fibrolamellar carcinoma of the liver. Lancet 1:538–540, 1984.PubMedCrossRefGoogle Scholar
  11. 11.
    Wood JR, Melia WM, Wood SM, et al: Neurotensin and hepatocellular carcinoma. (Letter to the editor.) Lancet 1:687, 1984.PubMedCrossRefGoogle Scholar
  12. 12.
    Teitelbaum DH, Tuttle S, Carey LC, et al: Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor. Ann Surg 202:36–41, 1985.PubMedCrossRefGoogle Scholar
  13. 13.
    Friedman AC, Lichtenstein JE, Goodman ZD, et al: Fibrolamellar hepatocellular carcinoma. Radiology 157:583–587, 1985.PubMedGoogle Scholar
  14. 14.
    Francis IR, Agha FP, Thompson NW, et al: Fibrolamellar hepatocarcinoma: Clinical, radiologic and pathologic features. Gastrointest Rad 11:67–72, 1986.CrossRefGoogle Scholar
  15. 15.
    Wong LK, Link DP, Frey CF, et al: Fibrolamellar hepatocarcinoma: Radiology, management and pathology. AJR 139:172–175, 1982.PubMedGoogle Scholar
  16. 16.
    Caballero T, Aneiros J, Lopez-Caballero J, et al: Fibrolamellar hepatocellular carcinoma. An immunohisto-chemical and ultrastructural study. Histopathology 9:445–456, 1985.PubMedCrossRefGoogle Scholar
  17. 17.
    Lefkowitch JH, Muschel R, Price JB, et al: Copper and copper-binding protein in fibrolamellar liver cell carcinoma. Cancer 51:97–100, 1983.PubMedCrossRefGoogle Scholar
  18. 18.
    Stromeyer FW, Ishak KG, Gerber MA, et al: Ground glass cells in hepatocellular carcinoma. Am J Clin Pathol 74:254–258, 1980.PubMedGoogle Scholar
  19. 19.
    Sheahan DG: Fibrolamellar carcinoma of the liver: An immunohistochemical study. Lab Invest 54:57, 1986 (abst).Google Scholar
  20. 20.
    Goodman ZD, Ishak KG, Langloss JM, et al: Combined hepatocellular-cholangiocellular carcinoma. A histologic and immunohistologic study. Cancer 55:124–135, 1985.PubMedCrossRefGoogle Scholar
  21. 21.
    Vecchio FM, Fabrino A, Ghirlanda G, et al: Fibrolamellar carcinoma of the liver: The malignant counterpart of focal nodular hyperplasia with oncocytic change. Am J Clin Pathol 81:521–526, 1984.PubMedGoogle Scholar
  22. 22.
    An T, Ghatak N, Kastner R, et al: Hyaline globules and intracellular lumina in a hepatocellular carcinoma. Am J Clin Pathol 79:392–396, 1983.PubMedGoogle Scholar
  23. 23.
    Baithum SI, Pollock DJ: Oncocytic hepatocellular tumor. Histopathology 7:107–112, 1983.CrossRefGoogle Scholar
  24. 24.
    Farhi DC, Shikes RH, Silverberg SG: Ultrastructure of fibrolamellar oncocytic hepatoma. Cancer 50:702–709, 1982.PubMedCrossRefGoogle Scholar
  25. 25.
    Mierau GW, Orsini EN: Case for diagnosis. Ultrastruct Pathol 5:273–279, 1983.PubMedCrossRefGoogle Scholar
  26. 26.
    Nagorney DM, Adson MA, Weiland LH, et al: Fibrolamellar hepatoma. Am J Surg 149:113–119, 1985.PubMedCrossRefGoogle Scholar
  27. 27.
    Lack EE, Neave C, Vawter GF: Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence. Cancer 52:1510–1515, 1983.PubMedCrossRefGoogle Scholar
  28. 28.
    Craig JR, Van Thiel DH: Fibrolamellar carcinoma, in Ishak KG (ed): Hepatopathology 1985. Syllabus of the Postgraduate Course of the American Association for the Study of Liver Disease, Chicago, 3–4, Nov. 1985. Slack, Thorofare, New Jersey, pp. 361–371.Google Scholar
  29. 29.
    Starzl TE, Iwatsuki S, Shaw BW, et al: Treatment of fibrolamellar hepatoma with partial or total hepatec-tomy and transplantation of the liver. Surg Gynecol Obstet 162:145–148, 1986.PubMedGoogle Scholar
  30. 30.
    Ihde DC, Matthews MJ, Makuch RN, et al.: Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival. Am J Med 78:399–406, 1985.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1989

Authors and Affiliations

  • Donald B. Rolfes
    • 1
  1. 1.Department of PathologyHoly Cross HospitalSilver SpringUSA

Personalised recommendations